graduation at Farmácia Bioquímica from Universidade de São Paulo (2000), master's at Pharmacy from Universidade de São Paulo (2002) and doctorate at Pharmacy from Universidade de São Paulo (2005). Has experience in Microbiology, focusing on Applied Microbiology, acting on the following subjects: vre, mrsa, fatores de virulência, enterococcus and resistência. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Streptococcus agalactiae, or group B Streptococcus, is a human pathogen recognized worldwide for neonatal mortality as well as infections in pregnant women and debilitated adults with significant mortality. Equitably, it is a relevant pathogen in animal health, with mastitis being the main source of economic losses in dairy herds of regions without control strategies. Strategies for preve…
Daptomycin is one of the last alternatives for treatment of infections caused by vancomycin-resistant enterococci (VRE), especially in clonal complex 17 E. faecium, so-called of "high risk". However, resistance and therapeutic failure have already been observed and genes with mutations, such as liaFSR and yycFGHIJ have been suggested as responsible. However, the mechanism of resistance is…
Multi-resistant and virulent strains of MRSA have spread in many hospitals around the world and there are few therapies available to treat infections caused by this pathogen. In this study, 150 isolates from different sites of infection or colonization from hospitalized patients in Brazilian hospitals will be analyzed. These results will be important for the hospitals staff to know whethe…
The emergence of Multiple Drug Resistance (MDR), a consequence of the exorbitant use of antibiotics, allied with the pharmaceutical industry's lack of investment in the discovery of new drugs, has resulted in a worldwide alert due to the scarcity of therapeutic options for bacterial infections. In this scenario, interests in the search for new antimicrobial compounds increases. Given the …
The discovery of antibiotics has revolutionized medical treatment by reducing mortality caused by pathogens, but indiscriminate use has targeted multiresistant microorganisms that can generate aggressive outbreaks of nosocomial infections. In addition, the decrease in investments by the pharmaceutical industry for the discovery of new antibiotics resulted in a lower production rate than t…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 2 / 2 | Completed research grants |
| 10 / 8 | Completed scholarships in Brazil |
| 13 / 11 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID